Advertisement

Cancer of the Oesophagus

  • R. Giulì

Abstract

There are still no unanimous opinions, or even a general consensus, among those in various specialties in different parts of the world who have to treat patients with cancer of the oesophagus. However, for the time being, surgical therapy seems to be recognized as the treatment of choice whenever feasible. Attempts to improve the results currently involve the association, before, sometimes during and often after surgery, of other modes of treatments.

Keywords

Esophageal Cancer Esophageal Carcinoma Preoperative Radiotherapy Oesophageal Cancer Prognostic Nutritional Index 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akiyama H (1984 a) Which groups of lymph nodes draining the esophagus could be usually excised during operation? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 90Google Scholar
  2. Akiyama H (1984 b) What are the rules for tubulisation of the stomach to be possible? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 146Google Scholar
  3. Akiyama H (1984 c) Are there still indications for manual anastomosis in esophageal surgery? In: Giuli R, (ed) Cancer of the esophagus in 1984. p 67Google Scholar
  4. Angorn IB, Haffejee AA (1984 a) May contra–indications be nutritional or immunological? Is there a relationship between these two factors? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 21Google Scholar
  5. Angorn IB, Haffejee AA (1984 b) Do nutritional and immunological factors have prognostic value in carcinoma of the esophagus? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 370Google Scholar
  6. Angorn IB, Haffejee AA (1984 c) At what time should intubation of the esophagus be considered, and according to what technique? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 43Google Scholar
  7. Balzola F, Schimenti P, Possamai D (1984) Are there immunological or nutritional arguments which may be used to predict inoperability? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 106Google Scholar
  8. Belsey R (1984) Is it possible to talk of cure of carcinoma of the esophagus? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 382Google Scholar
  9. Blackburn G (1984) Is it possible to reverse the catabolism of a patient? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 67Google Scholar
  10. Bourgeon A, Richelme H (1984) The direction of peristalsis would not seem to play a predominant role in the function of a colonic transplant. In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 271Google Scholar
  11. Burtin C, Noirot C, Scheinmann P (1984) Biological factors as markers of progression in oncology. In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 298Google Scholar
  12. Chomé J (1984 a) Is the diagnosis of superficial carcinoma always possible? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 325Google Scholar
  13. Chomé J (1984 b) The problem of neoplastic repermeation. In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 325Google Scholar
  14. Chomé J (1984 c) How to classify certain unequal aspects of histological differentiation? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 213Google Scholar
  15. Couraud L, Meriot S, Haffez A (1984) Functional sequelae of esophageal resections. In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, pp 276–279Google Scholar
  16. Del Genio A, di Martino M, Amato G, Fei L (1984) Many prognostic factors cannot be investigated surgically. In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 200Google Scholar
  17. Desai PB, Advani SH, Dinshaw KA, et al. (1985) The long term impact of front-loading chemotherapy in advanced esophageal cancers. A report of 88 patients treated with cisplatin methotrexate. In: Abstracts of the 1st International Congress on Neo-Adjuvant Chemotherapy. Paris (under the patronage of the UICC, INSERM and French National League against cancer)Google Scholar
  18. Doggett R, Guernsey J (1970) Combined radiation and surgical treatment of the thoracic esophagus: final report. Front Radiat Ther Oncol 5: 147–154Google Scholar
  19. Ellis F Jr (1984) Should palliative operations still be considered? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 49Google Scholar
  20. Elman A, Giuli R (1988) Immediate complications following esophageal surgery. In: Delarue NC, Eschapasse H, (eds): International trends in general thoracic surgery. Saunders, TorontoGoogle Scholar
  21. Elman A, Boudinet A, Flamant Y, Metrot-Magny C, Levy D (1984) Contraindications related to respiratory function. In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 20Google Scholar
  22. Endo M (1984) Should surgical treatment of superficial cancers be limited? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 336Google Scholar
  23. Gignoux M, et al. (1985) Pre-operative radiotherapy for carcinoma of the esophagus. Results of a prospective multicentric study (EORTC) in esophageal disorders: pathophysiology and therapy. In: DeMester TR, Skinner DB, (eds) Raven, New YorkGoogle Scholar
  24. Girault F (1984) At what time should intubation of the esophagus be considered, and according to what technique? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 45Google Scholar
  25. Giuli R. (ed) (1984 a) Cancer of the esophagus in 1984. Maloine, ParisGoogle Scholar
  26. Giuli R (1984 b) Gastric resection in esophageal cancer. In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 288Google Scholar
  27. Giuli R (1988 a) Viewpoint on the association of radiotherapy and surgery. In: Wilkins EW Jr, Delarve NC, (eds) International trends in general thoracic surgery; vol 4, Esophageal cancer. Saunders, TorontoGoogle Scholar
  28. Giuli R (1988 b) Surgery for squamous carcinoma of the oesophagus. An overview. In: Jamieson GG, (ed) Surgery of the oesophagus. Churchill Livingstone, EdinburghGoogle Scholar
  29. Giuli R (1988 c) Surgical involvement in cooperative study protocols: experience of the OESO international group. In: Wilking EW, Delarve NC, (eds) International trends in general thoracic surgery; vol 4, Esophageal cancer. Saunders, TorontoGoogle Scholar
  30. Giuli R, Gignoux M (1980) Treatment of carcinoma of the esophagus. Retrospective study of 3400 patients. Ann Surg 192: 44–52PubMedCrossRefGoogle Scholar
  31. Giuli R, Sancho-Garnier H (1986) Diagnostic, therapeutic and prognostic features of cancers of the esophagus. Results of the international prospective study conducted by the OESO group (790 patients). Surgery, 99: 614–622PubMedGoogle Scholar
  32. Herrmann R, Schlag P, Manegold C, et al. (1985) Preoperative chemotherapy in esophageal cancer. Results of a phase II pilot study. In: Abstracts of the 1st International Congress on Neo-Adjuvant Chemotherapy. Paris (under the patronage of the UICC, INSERM and French National League against cancer)Google Scholar
  33. Huang GJ (1984 a) Is it possible to define correlation between the presymptomatic period and the stage of carcinoma? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 324Google Scholar
  34. Huang GJ (1984 b) What is the value of abrasive cytology? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 325Google Scholar
  35. Huang GJ (1984 c) Is the type of thoracic approach of importance? In: Giuli R, (ed) Cancer of esophagus in 1984. Maloine, Paris, p 89Google Scholar
  36. Huang GJ (1984 d) What is the value of abrasive cytology? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 320Google Scholar
  37. Huang GJ (1984 e) How to treat superficial carcinoma? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maline, Paris, p 331Google Scholar
  38. Huang GJ (1984 f) In other cases, surgery can be envisaged. Pre–operative radiotherapy or chemotherapy. In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p56Google Scholar
  39. Husemann B (1984) In other cases, surgery can be envisaged. Preoperative radiotherapy or chemotherapy. In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p56Google Scholar
  40. Kamano T, Kishino H, Kidokoro T, et al. (1983) Oral administration of oil bleomycin combined with sodium polyacrylate for the treatment of esophageal cancer. Am J Med 75 (4): 104Google Scholar
  41. Kelsen D (1984) Chemotherapy of esophageal cancer. Semin Oncol 11: 159PubMedGoogle Scholar
  42. Kelsen D, Hilaris B, Coonley C (1983 a) Cisplatin, vindesine, and bleomycin chemotherapy of local–regional and advanced esophageal carcinoma. Am J Med 75 (4): 645–652PubMedCrossRefGoogle Scholar
  43. Kelsen D, Heelan R, Coonley C, et al. (1983 b) Clinical and pathological evaluation of response chemotherapy in patients with esophageal carcinoma. Am J Med 75(4): 103CrossRefGoogle Scholar
  44. Kolaric K, Roth A, Dujmovic I (1985) The value of two combined chemoradiotherapy approaches in the treatment of inoperable esophageal cancer. In: Abstracts on cancer chemotheray. Nippon Kayaku, Tokyo, p 136Google Scholar
  45. Krakoff IH, Newman RA, Hacker MP (1985) Modification of bleomycin pulmonary toxicity by inhibitors of collagen synthesis. In: Abstracts on cancer chemotherapy. Nippon Kayaku, Tokyo, p 180Google Scholar
  46. Launois B, et al. (1981) Pre-operative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 153: 690–692PubMedGoogle Scholar
  47. Lebas JF, Sarrazin R, Coulomb M, Geindre M (1984) How dependable is computerized tomography in determining contraindications? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 29Google Scholar
  48. Mignon M, de Mestier P, Zielinski B (1984) The problem of remaining gastric acidity. In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 280Google Scholar
  49. Moraldi A, Zerilli M, Iascone C, Schillaci A, Stipa S (1984) Can the scanner supply sufficient elements to specify the state of the detected lymph nodes? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 92Google Scholar
  50. Mullen JL, Buzby GP, Matthews DC, et al. (1980) Reduction of operative morbidity and mortality by combined preoperative and postoperative nutritional support. Ann Surg 102: 604–613Google Scholar
  51. Orringer MB (1984) Is it illusory to envisage extended lymph node dissection? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 138Google Scholar
  52. Payne WS (1984) The role of esophageal blood supply. In: Giuli R, (ed) Cancer of the esophagus in 1984. 135 questions. Maloine, Paris, p 222Google Scholar
  53. Pearson JG (1984) Should radiotherapy be considered? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 33Google Scholar
  54. Picus D (1983) Computed tomography in the staging of esophageal carcinoma. Radiology 146: 433–438PubMedGoogle Scholar
  55. Pissas A, Dyon JF, Sarrazin R, Bouchet Y (1979) Le drainage lymphatique de I’estomac. J Chir (Paris) 116: 583–590Google Scholar
  56. Ribet M (1984) What immune studies should be undertaken in cancer of the oesophagus? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 26Google Scholar
  57. Richelme H (1984) Does sub-total resection necessarily require a cervical approach to the esophagus? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 134Google Scholar
  58. Sarrazin R, Voilin C, Bade B, Dyon JF (1984) Lymph node anatomy and physiology of the oesophagus. In: Giuli R, (ed) Cancer of the esophagus in 1984.. Maloine, Paris, p 5Google Scholar
  59. Savary M, Monnier P, Anani P (1984) What should the attitude be in the presence of esophageal dysplasia or healthy esophagus? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 335Google Scholar
  60. Schlag P, et al. (1985) Cisplatin, vindesine and bleomycin chemotherapy prior to surgery in esophageal carcinoma. International Symposium on Chemotherapy Prior to Surgery or Radiation. February, Valkenberg, (in press)Google Scholar
  61. Siewert JR (1984) Quality of resection: invasion of lymph nodes or neighbouring organs. In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 198Google Scholar
  62. Skinner DB (1984) Is it legitimate to envisage the combined excision of an organ invaded by contact with the tumour? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 101Google Scholar
  63. Sugimachi K, Inokuchi K, Kai H, et al. (1983) Hyperthermo–chemo–therapy for carcinoma of the esophagus. Am J Med 75 (4): 103CrossRefGoogle Scholar
  64. Sugimachi K, Inokuchi K, Natsuda Y, et al. (1982) Intraoperative local adjuvant cancer chemotherapy for carcinoma of the thoracic esophagus. Jpn J Surg 12: 105–110PubMedCrossRefGoogle Scholar
  65. Watanabe H (1983) Adjuvant chemotherapy combined with surgical treatment for cancer of the esophagus. In: Abstracts on cancer chemotherapy. Nippon Kayaku, Tokyo, PiGoogle Scholar
  66. Wong J (1984) What are the methods available to assess the quality of surgical resection? In: Giuli R, (ed) Cancer of the esophagus in 1984. Maloine, Paris, p 198Google Scholar
  67. Wong J (1985) Progress in esophageal surgery. Congres de 1’Association Francaise de Chirurgie, Sept 26, ParisGoogle Scholar
  68. Yamada S, Asakawa H, Matsumoto K, et al. (1984) Combination therapy with radiation and bleomycin for esophageal carcinoma with special reference to the prognostic aspect. In: Abstracts on cancer chemotherapy. Nippon Kayaku, Tokyo, p 86Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • R. Giulì

There are no affiliations available

Personalised recommendations